These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1715550)

  • 1. Clinical electrophysiological effects of intravenous recainam: an antiarrhythmic drug under investigation for the treatment of ventricular and supraventricular arrhythmias.
    Feld GK; Luceri RM; Greenspon AJ; Singh BN; Horowitz LN; Capuzzi DM; Frame VB; Myerburg RJ
    Pacing Clin Electrophysiol; 1991 Jul; 14(7):1129-37. PubMed ID: 1715550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic and pharmacokinetic evaluation of intravenous recainam in patients with frequent ventricular premature complexes and unsustained ventricular tachycardia.
    Anderson JL; Reddy CP; Myerburg RJ; Waxman HL; de Vane PJ
    Am J Cardiol; 1993 Mar; 71(8):686-94. PubMed ID: 8447266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic effects and antiarrhythmic efficacy of recainam in patients with supraventricular tachycardia.
    Tai YT; Campbell RW; McComb JM
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):310-5. PubMed ID: 1709237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of N-acetylprocainamide and recainam in the pharmacologic conversion and suppression of experimental canine atrial flutter: significance of changes in refractoriness and conduction.
    Feld GK; Venkatesh N; Singh BN
    J Cardiovasc Pharmacol; 1988 May; 11(5):573-80. PubMed ID: 2455844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac electrophysiology of the antiarrhythmic agent recainam (Wy-42,362) in anesthetized dogs: relation to plasma and myocardial concentrations.
    Colatsky TJ; Bird LB; Knowles JA
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):308-16. PubMed ID: 2452923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recainam, a potent new antiarrhythmic agent: effects on complex ventricular arrhythmias.
    Anastasiou-Nana MI; Anderson JL; Hampton EM; Nanas JN; Heath BM
    J Am Coll Cardiol; 1986 Aug; 8(2):427-35. PubMed ID: 3734265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of recainam on the energy required for ventricular defibrillation in dogs as assessed with implanted electrodes.
    Frame LH; Sheldon JH
    J Am Coll Cardiol; 1988 Sep; 12(3):746-52. PubMed ID: 3403835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological effects of a new antiarrhythmic agent, nicainoprol, in humans.
    Sen S; Rettig G; Ozbek C; Fröhlig G; Schieffer H; Bette L
    J Cardiovasc Pharmacol; 1986; 8(1):144-50. PubMed ID: 2419677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological effects of disopyramide in patients with bundle branch block.
    Desai JM; Scheinman M; Peters RW; O'Young J
    Circulation; 1979 Feb; 59(2):215-25. PubMed ID: 758989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of vernakalant (RSD1235), an investigational antiarrhythmic agent, on atrial electrophysiology in humans.
    Dorian P; Pinter A; Mangat I; Korley V; Cvitkovic SS; Beatch GN
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):35-40. PubMed ID: 17666913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recainam dose titration and pharmacokinetics in patients with resistant arrhythmias.
    Davies RF; Lineberry MD; Funck-Brentano C; Echt DS; Lee JT; Capuzzi DM; Roden DM; Woosley RL
    Clin Pharmacol Ther; 1989 Sep; 46(3):324-34. PubMed ID: 2673622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethmozine: electrophysiology, hemodynamics, and antiarrhythmic efficacy in patients with life-threatening ventricular arrhythmias.
    Dorian P; Echt DS; Mead RH; Lee JT; Lebsack CS; Winkle RA
    Am Heart J; 1986 Aug; 112(2):327-33. PubMed ID: 3526852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
    Roden DM; Lee JT; Woosley RL; Echt DS
    Circulation; 1989 Nov; 80(5):1247-58. PubMed ID: 2805262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The disposition of recainam hydrochloride during and after intravenous loading and maintenance infusion in cardiac patients.
    Hampton EM; Anastasiou-Nana MI; Nanas JN; Nappi JM; Capuzzi DM; Anderson JL
    J Clin Pharmacol; 1987 Dec; 27(12):951-6. PubMed ID: 3437067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of recainam, a new antiarrhythmic drug, for control of ventricular arrhythmias.
    Anderson JL; Anastasiou-Nana MI; Heath BM; Menlove RL; Nanas JN; Friedman J
    Am J Cardiol; 1987 Aug; 60(4):281-7. PubMed ID: 2441587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
    Fujiki A; Tani M; Mizumaki K; Shimono M; Inoue H
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):374-8. PubMed ID: 7515979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular electrophysiology of the new antiarrhythmic agent recainam (Wy-42,362) in canine cardiac Purkinje fibers.
    Colatsky TJ; Bird LB; Jurkiewicz NK; Wendt RL
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):435-44. PubMed ID: 2438506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of use-dependent ventricular conduction slowing by antiarrhythmic drugs in humans.
    Ranger S; Talajic M; Lemery R; Roy D; Villemaire C; Nattel S
    Circulation; 1991 Jun; 83(6):1987-94. PubMed ID: 2040051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiologic effects of cibenzoline in humans related to dose and plasma concentration.
    Touboul P; Atallah G; Kirkorian G; de Zuloaga C; Dufour A; Aymard MF; Lavaud P; Moleur P
    Am Heart J; 1986 Aug; 112(2):333-9. PubMed ID: 3526853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic effects and efficacy of recainam for sustained ventricular tachycardia.
    de Buitleir M; Kou WH; Nelson SD; Schmaltz S; Morady F
    Am J Cardiol; 1989 Jan; 63(1):116-8. PubMed ID: 2642366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.